| scholarly article | Q13442814 |
| P50 | author | Anna J Stevenson | Q57301814 |
| Katie Marwick | Q58473640 | ||
| P2093 | author name string | Stephen M Lawrie | |
| Caitlin Davies | |||
| P2860 | cites work | Personalised cancer medicine | Q26991908 |
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| The contribution of de novo coding mutations to autism spectrum disorder | Q28250812 | ||
| The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application. | Q33439138 | ||
| Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. | Q52268247 | ||
| Is this muscle pain caused by my statin? | Q54580606 | ||
| Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials | Q57286644 | ||
| N of 1 randomized trials for investigating new drugs | Q68462159 | ||
| Reducing persistent auditory hallucinations by wearing an ear-plug | Q69565280 | ||
| L-dopa in the treatment of negative schizophrenic symptoms: a single-subject experimental study | Q69873147 | ||
| Determining optimal therapy--randomized trials in individual patients | Q69989570 | ||
| A simple, repeated rTMS protocol effectively removes auditory verbal hallucinations in a single patient study | Q87331380 | ||
| Meta-analysis of individual participant data: rationale, conduct, and reporting | Q33530020 | ||
| The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies | Q33577793 | ||
| GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine | Q33604210 | ||
| A clinician's guide for conducting randomized trials in individual patients | Q34102092 | ||
| A multiple imputation strategy for sequential multiple assignment randomized trials | Q34287887 | ||
| Smartphones for smarter delivery of mental health programs: a systematic review | Q34385613 | ||
| Using n-of-1 trials as a clinical tool to improve prescribing. | Q34620115 | ||
| CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration | Q35632264 | ||
| N-of-1 trials are a tapestry of heterogeneity. | Q35990310 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research | Q37678444 | ||
| N-of-1 trials in the medical literature: a systematic review | Q37863449 | ||
| The Impact of Patient Participation in Health Decisions Within Medical Encounters: A Systematic Review. | Q38638986 | ||
| Prevalence and architecture of de novo mutations in developmental disorders | Q38991782 | ||
| The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. | Q40145512 | ||
| CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement | Q41483522 | ||
| Donepezil in schizophrenia--is it helpful? An experimental design case study | Q43848500 | ||
| The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development | Q44543027 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 398-403 | |
| P577 | publication date | 2018-05-10 | |
| P1433 | published in | British Journal of Psychiatry | Q4035428 |
| P1476 | title | Application of n-of-1 treatment trials in schizophrenia: systematic review | |
| P478 | volume | 213 |
| Q63952812 | Application of n-of-1 treatment trials in schizophrenia: systematic review - ERRATUM |
| Q92013608 | The Feasibility of Using N-Of-1 Trials to Investigate Deprescribing in Older Adults with Dementia: A Pilot Study |
| Q93023627 | The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis |
Search more.